DK165168C - Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer - Google Patents

Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer

Info

Publication number
DK165168C
DK165168C DK204484A DK204484A DK165168C DK 165168 C DK165168 C DK 165168C DK 204484 A DK204484 A DK 204484A DK 204484 A DK204484 A DK 204484A DK 165168 C DK165168 C DK 165168C
Authority
DK
Denmark
Prior art keywords
piroxicam
preparing
depended
bear
procedure
Prior art date
Application number
DK204484A
Other languages
Danish (da)
English (en)
Other versions
DK165168B (da
DK204484D0 (da
DK204484A (da
Inventor
Melvin Mackenzie Noseworthy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK204484D0 publication Critical patent/DK204484D0/da
Publication of DK204484A publication Critical patent/DK204484A/da
Publication of DK165168B publication Critical patent/DK165168B/da
Application granted granted Critical
Publication of DK165168C publication Critical patent/DK165168C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
DK204484A 1983-04-25 1984-04-24 Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer DK165168C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25
US48830383 1983-04-25

Publications (4)

Publication Number Publication Date
DK204484D0 DK204484D0 (da) 1984-04-24
DK204484A DK204484A (da) 1984-10-26
DK165168B DK165168B (da) 1992-10-19
DK165168C true DK165168C (da) 1993-03-08

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK204484A DK165168C (da) 1983-04-25 1984-04-24 Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer

Country Status (28)

Country Link
EP (1) EP0123520B1 (fi)
JP (1) JPS59205375A (fi)
KR (1) KR840008345A (fi)
AT (1) ATE36531T1 (fi)
AU (1) AU548451B2 (fi)
BG (1) BG40810A3 (fi)
CA (1) CA1213220A (fi)
CS (1) CS246078B2 (fi)
DD (1) DD219672A5 (fi)
DE (1) DE3473454D1 (fi)
DK (1) DK165168C (fi)
EG (1) EG17887A (fi)
ES (1) ES8505365A1 (fi)
FI (1) FI82377C (fi)
GR (1) GR81938B (fi)
GT (1) GT198404085A (fi)
HU (1) HU194217B (fi)
IE (1) IE57327B1 (fi)
IL (1) IL71598A (fi)
MX (1) MX159889A (fi)
NO (1) NO165177C (fi)
NZ (1) NZ207930A (fi)
PH (1) PH18864A (fi)
PL (1) PL144064B1 (fi)
PT (1) PT78473B (fi)
RO (1) RO88420A (fi)
YU (1) YU44232B (fi)
ZA (1) ZA843013B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN160683B (fi) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
PH18864A (en) 1985-10-21
EP0123520B1 (en) 1988-08-17
PL247378A1 (en) 1985-03-26
IE840982L (en) 1984-10-25
DD219672A5 (de) 1985-03-13
RO88420A (ro) 1986-01-30
NO165177C (no) 1991-01-09
IL71598A (en) 1987-01-30
HUT34023A (en) 1985-01-28
EP0123520A1 (en) 1984-10-31
ES531866A0 (es) 1985-05-16
DK165168B (da) 1992-10-19
FI82377B (fi) 1990-11-30
CA1213220A (en) 1986-10-28
DK204484D0 (da) 1984-04-24
JPH0251527B2 (fi) 1990-11-07
NO841611L (no) 1984-10-26
YU44232B (en) 1990-04-30
EG17887A (en) 1991-03-30
KR840008345A (ko) 1984-12-14
ZA843013B (en) 1985-12-24
IL71598A0 (en) 1984-07-31
DE3473454D1 (en) 1988-09-22
NO165177B (no) 1990-10-01
HU194217B (en) 1988-01-28
MX159889A (es) 1989-09-27
BG40810A3 (en) 1987-02-16
GR81938B (fi) 1984-12-12
JPS59205375A (ja) 1984-11-20
FI841604A0 (fi) 1984-04-24
FI841604A (fi) 1984-10-26
PL144064B1 (en) 1988-04-30
DK204484A (da) 1984-10-26
PT78473B (en) 1986-08-28
NZ207930A (en) 1986-09-10
GT198404085A (es) 1985-10-16
ES8505365A1 (es) 1985-05-16
YU72484A (en) 1988-04-30
PT78473A (en) 1984-05-01
AU548451B2 (en) 1985-12-12
ATE36531T1 (de) 1988-09-15
CS246078B2 (en) 1986-10-16
AU2716084A (en) 1984-11-01
IE57327B1 (en) 1992-07-29
FI82377C (fi) 1991-03-11

Similar Documents

Publication Publication Date Title
SE8601103D0 (sv) Neue, schwefelhaltige 5-substituierte benzimidazol-derivate und verfahren zu ihrer herstellung
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
IS3789A7 (is) Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
DK165168C (da) Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
ES8304975A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
JPS5239640A (en) Process for preparation of 1,2- propanediol derivatives

Legal Events

Date Code Title Description
PBP Patent lapsed